Meng Rui Chang

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Meng Rui Chang

Mar 22, 2025, 07:56 | Science

Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors - The Babak Lab

The Babak Lab shared an article by Meng Rui Chang, et al. on LinkedIn: "Read…

Feb 27, 2025, 13:11 | Blog

Enhancing Immune Response in Mesothelioma via Immunogenic Cell Death - The Babak Lab

The Babak Lab shared a post on LinkedIn: "Scientific Wednesdays: Exciting News from The Babak…

Jan 24, 2025, 15:18 | Blog

Jemma Arakelyan: Transition metal complexes as an approach for targeting emerging cancer hallmarks

Jemma Arakelyan, Medical Oncologist, CEO at the Institute of Cancer and Crisis, shared a post…

Jan 23, 2025, 14:32 | Insight

Transition metal complexes as an approach for targeting emerging cancer hallmarks - The Babak Lab

The Babak Lab shared a post on LinkedIn: "Scientific Wednesday։ Transition metal complexes as an…

All: 4 Posts: 1 - 100

'

ASCO 2025 for Trainees and Residents: Your Ultimate Guide to Success

'

ctDNA after surgery for MMRd tumors can prevent cancer recurrence - Yelena Janjigian at AACR25

'

Top Growing Medical Universities in the Post-Soviet Region – BIGR 2025 Edition

'

Organ Preservation in dMMR Tumors: Results from Neoadjuvant Phase II Study with Dostarlimab

'

POEM 2025 Scientific Meeting: Key Sessions, Workshops, and Why You Should Attend

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023